Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions, 38303 [2012-15715]

Download as PDF Federal Register / Vol. 77, No. 124 / Wednesday, June 27, 2012 / Notices 38303 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration Food and Drug Administration [Docket No. FDA–2011–N–0793] [Docket No. FDA–2010–N–0465] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Medical Device Recall Authority Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Study: Effect of Promotional Offers in Direct-toConsumer Prescription Drug Print Advertisements on Consumer Product Perceptions [Docket No. FDA–2011–N–0797] AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Medical Device Recall Authority’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 5156, Daniel.Gittleson@fda.hhs.gov. On February 13, 2012, the Agency submitted a proposed collection of information entitled ‘‘Medical Device Recall Authority’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0432. The approval expires on June 30, 2015. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: June 18, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012–15717 Filed 6–26–12; 8:45 am] srobinson on DSK4SPTVN1PROD with NOTICES BILLING CODE 4160–01–P AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Experimental Study: Effect of Promotional Offers in Direct-toConsumer Prescription Drug Print Advertisements on Consumer Product Perceptions’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50–400B, Rockville, MD 20850, 301– 796–7651, Juanmanuel.Vilela@fda.hhs.gov. On October 14, 2011, the Agency submitted a proposed collection of information entitled ‘‘Experimental Study: Effect of Promotional Offers in Direct-toConsumer Prescription Drug Print Advertisements on Consumer Product Perceptions’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0713. The approval expires on June 30, 2015. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. SUPPLEMENTARY INFORMATION: Dated: June 18, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012–15715 Filed 6–26–12; 8:45 am] BILLING CODE 4160–01–P VerDate Mar<15>2010 19:05 Jun 26, 2012 Jkt 226001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; State Enforcement Notifications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘State Enforcement Notifications’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Denver Presley, II, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 3793. SUPPLEMENTARY INFORMATION: On March 19, 2012, the Agency submitted a proposed collection of information entitled ‘‘State Enforcement Notifications’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0275. The approval expires on June 30, 2015. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. SUMMARY: Dated: June 18, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012–15707 Filed 6–26–12; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2012–N–0253] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Postmarketing Adverse Drug Experience Reporting AGENCY: Food and Drug Administration, HHS. ACTION: E:\FR\FM\27JNN1.SGM Notice. 27JNN1

Agencies

[Federal Register Volume 77, Number 124 (Wednesday, June 27, 2012)]
[Notices]
[Page 38303]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15715]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0465]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Experimental Study: Effect of 
Promotional Offers in Direct-to-Consumer Prescription Drug Print 
Advertisements on Consumer Product Perceptions

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Experimental Study: Effect of 
Promotional Offers in Direct-to-Consumer Prescription Drug Print 
Advertisements on Consumer Product Perceptions'' has been approved by 
the Office of Management and Budget (OMB) under the Paperwork Reduction 
Act of 1995.

FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-7651, 
Juanmanuel.Vilela@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On October 14, 2011, the Agency submitted a 
proposed collection of information entitled ``Experimental Study: 
Effect of Promotional Offers in Direct-to-Consumer Prescription Drug 
Print Advertisements on Consumer Product Perceptions'' to OMB for 
review and clearance under 44 U.S.C. 3507. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number. 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0713. The approval expires on June 30, 2015. A copy 
of the supporting statement for this information collection is 
available on the Internet at https://www.reginfo.gov/public/do/PRAMain.

    Dated: June 18, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-15715 Filed 6-26-12; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.